Biomedical Catalyst – Digital Healthcare Platform for Early Dementia Diagnosis

英国70万痴呆症患者中的大多数人没有得到正式诊断，因此无法获得有益的治疗。目前的NHS方法是缓慢的（往往超过12个月），往往质量低下。该项目将开发一种新型的数字医疗保健系统，使痴呆症诊断能够在疾病过程中快速，经济有效地进行。它将基于计算机的记忆和思维测试与MRI大脑扫描的计算机分析结合起来，这已经在研究中使用了好几年。它将提供诊断支持，向治疗所有病人的医生提供目前仅在高度专科中心提供的高质量信息，目的是将诊断时间缩短到3个月。我们将建立和测试一个原型，并证明其价值，然后再开发一个完善的原型，可以推出全国。

Most of the 700,000 people in the UK with dementia have not received a formal diagnosis, so are denied access to beneficial treatments. The current NHS approach is slow (often more than 12 months) and often of low quality. This project will develop a novel digital healthcare system that will allow dementia diagnoses to be made quickly, cost effectively, and earlier in the disease course. It makes a novel combination of computer-based tests of memory and thinking and computerized analysis of MRI brain scans, which have been used in research for several years. It will provide support in diagnosis, making available the quality of information currently only available in highly specialist centres to doctors treating all patients, with the aim of reducing time to diagnosis to 3 months. We will build and test a prototype and demonstrate its value before developing a refined prototype that can be rolled-out nationally.